E
ExaWizards Inc
TSE:4259
ExaWizards Inc
TSE:4259
Price:
672
JPY
-1.32%
Market Closed
Market Cap:
¥58.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
ExaWizards Inc
TSE:4259
|
JP |
|
United States Cellular Corp
NYSE:USM
|
US |
Income Statement
Earnings Waterfall
ExaWizards Inc
ExaWizards Inc
Income Statement
ExaWizards Inc
ExaWizards Inc
Currency: JPY
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
1
|
1
|
2
|
6
|
20
|
20
|
26
|
29
|
21
|
28
|
0
|
0
|
0
|
|
| Revenue |
6 007
N/A
|
5 461
-9%
|
5 531
+1%
|
5 591
+1%
|
5 697
+2%
|
6 357
+12%
|
7 305
+15%
|
8 384
+15%
|
9 192
+10%
|
9 592
+4%
|
9 799
+2%
|
9 811
+0%
|
10 147
+3%
|
10 453
+3%
|
11 028
+6%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(2 296)
|
(2 109)
|
(2 286)
|
(2 455)
|
(2 581)
|
(2 946)
|
(3 294)
|
(3 696)
|
(4 054)
|
(4 143)
|
(4 258)
|
(4 143)
|
(3 897)
|
(3 707)
|
(3 656)
|
|
| Gross Profit |
3 710
N/A
|
3 353
-10%
|
3 245
-3%
|
3 136
-3%
|
3 116
-1%
|
3 411
+9%
|
4 011
+18%
|
4 688
+17%
|
5 138
+10%
|
5 449
+6%
|
5 541
+2%
|
5 668
+2%
|
6 250
+10%
|
6 746
+8%
|
7 372
+9%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(4 149)
|
(3 512)
|
(3 514)
|
(3 514)
|
(3 605)
|
(4 036)
|
(4 492)
|
(4 993)
|
(5 384)
|
(5 465)
|
(5 556)
|
(5 645)
|
(8 301)
|
(8 296)
|
(6 084)
|
|
| Selling, General & Administrative |
(3 996)
|
(3 511)
|
(3 513)
|
(3 438)
|
(3 605)
|
(4 037)
|
(4 492)
|
(4 926)
|
(5 384)
|
(5 464)
|
(5 556)
|
(5 466)
|
(5 792)
|
(5 930)
|
(6 082)
|
|
| Research & Development |
0
|
0
|
0
|
(75)
|
0
|
0
|
0
|
(67)
|
0
|
0
|
0
|
(178)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(153)
|
0
|
0
|
(1)
|
0
|
1
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(2 509)
|
(2 366)
|
0
|
|
| Operating Income |
(438)
N/A
|
(159)
+64%
|
(269)
-69%
|
(378)
-40%
|
(489)
-29%
|
(625)
-28%
|
(481)
+23%
|
(305)
+37%
|
(246)
+19%
|
(16)
+93%
|
(15)
+6%
|
23
N/A
|
(2 051)
N/A
|
(1 550)
+24%
|
1 288
N/A
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(10)
|
(2)
|
(1)
|
(1)
|
(2)
|
(6)
|
(20)
|
(20)
|
(26)
|
(25)
|
(18)
|
(23)
|
(22)
|
(19)
|
(17)
|
|
| Non-Reccuring Items |
(84)
|
(38)
|
(38)
|
287
|
233
|
30
|
20
|
(366)
|
(325)
|
(265)
|
(247)
|
(2 508)
|
0
|
0
|
(2 372)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
4
|
0
|
1
|
1
|
2
|
|
| Total Other Income |
115
|
115
|
102
|
4
|
(2)
|
(2)
|
(5)
|
(5)
|
(1)
|
(1)
|
4
|
3
|
3
|
0
|
(5)
|
|
| Pre-Tax Income |
(416)
N/A
|
(84)
+80%
|
(206)
-145%
|
(88)
+57%
|
(260)
-195%
|
(603)
-132%
|
(486)
+19%
|
(692)
-42%
|
(594)
+14%
|
(303)
+49%
|
(272)
+10%
|
(2 505)
-821%
|
(2 069)
+17%
|
(1 568)
+24%
|
(1 104)
+30%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
15
|
20
|
12
|
(67)
|
(76)
|
(55)
|
(52)
|
59
|
72
|
52
|
(36)
|
(45)
|
(113)
|
(172)
|
(234)
|
|
| Income from Continuing Operations |
(401)
|
(64)
|
(194)
|
(155)
|
(336)
|
(658)
|
(538)
|
(633)
|
(522)
|
(251)
|
(308)
|
(2 550)
|
(2 182)
|
(1 740)
|
(1 338)
|
|
| Income to Minority Interest |
42
|
43
|
39
|
14
|
17
|
19
|
22
|
22
|
10
|
(7)
|
(22)
|
(25)
|
(26)
|
(32)
|
(34)
|
|
| Net Income (Common) |
(360)
N/A
|
(21)
+94%
|
(155)
-629%
|
(141)
+9%
|
(318)
-126%
|
(637)
-100%
|
(516)
+19%
|
(610)
-18%
|
(513)
+16%
|
(260)
+49%
|
(330)
-27%
|
(2 576)
-681%
|
(2 207)
+14%
|
(1 773)
+20%
|
(1 373)
+23%
|
|
| EPS (Diluted) |
-4.45
N/A
|
-0.26
+94%
|
-1.88
-623%
|
-1.72
+9%
|
-3.89
-126%
|
-7.87
-102%
|
-6.34
+19%
|
-7.49
-18%
|
-6.24
+17%
|
-3.16
+49%
|
-4
-27%
|
-31.25
-681%
|
-26.08
+17%
|
-20.31
+22%
|
-15.75
+22%
|
|
Switch to:
Switch to:
See Also
Discover More
